REGN - Regeneron Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 547.55B
Enterprise Value 3N/A
Trailing P/E 44.75
Forward P/E 127.08
PEG Ratio (5 yr expected) 11.65
Price/Sales (ttm)9.08
Price/Book (mrq)8.57
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6N/A

Financial Highlights

Fiscal Year
Fiscal Year Ends Dec 31, 2016
Most Recent Quarter (mrq)Jun 30, 2017
Profit Margin 22.05%
Operating Margin (ttm)32.29%
Management Effectiveness
Return on Assets (ttm)14.77%
Return on Equity (ttm)24.06%
Income Statement
Revenue (ttm)5.24B
Revenue Per Share (ttm)49.68
Quarterly Revenue Growth (yoy)21.20%
Gross Profit (ttm)4.56B
Net Income Avi to Common (ttm)1.15B
Diluted EPS (ttm)9.97
Quarterly Earnings Growth (yoy)97.60%
Balance Sheet
Total Cash (mrq)1.27B
Total Cash Per Share (mrq)11.96
Total Debt (mrq)701.17M
Total Debt/Equity (mrq)12.70
Current Ratio (mrq)3.75
Book Value Per Share (mrq)52.07
Cash Flow Statement
Operating Cash Flow (ttm)1.35B
Levered Free Cash Flow (ttm)996.19M

Trading Information

Stock Price History
Beta 1.66
52-Week Change 321.53%
S&P500 52-Week Change 320.27%
52 Week High 3543.55
52 Week Low 3325.35
50-Day Moving Average 3456.40
200-Day Moving Average 3456.24
Share Statistics
Avg Vol (3 month) 3739.85k
Avg Vol (10 day) 3706.67k
Shares Outstanding 5104.69M
Float 77.87M
% Held by Insiders 124.77%
% Held by Institutions 171.75%
Shares Short 32.44M
Short Ratio 33.33
Short % of Float 33.19%
Shares Short (prior month) 32.66M
Dividends & Splits
Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A